Tissue Regenix Share Discussion Threads

[timmy40] 23/3/2023 15:53

Sorry I cannot see this back at 0.50, the results were positive with +20% revenue across all divisions + cash in the bank to get to break even. The company is growing revenue in existing markets, particularly the US, as elective surgeries return/increase in frequency after Covid. They are expanding to new geographies/markets too, most probably China/Asia in the near future.The consolidation is required given the share price/no of shares in issue. A higher share price will mean the company is more marketable to institutions. It is v common in the US, which is the largest market by far for TRX and their board are Americans ? There is no dilution overall. This is all v good news. TRX's management are doing an excellent job but just imo.

[clocktower] 22/3/2023 10:47

The market is coming to accept consolidation is not positive.

How long before down below .50 ?

[b1inkers] 21/3/2023 12:31

Good set of results.

Roll those figures on to 2023 (constant revenue growth, fix gross margin and overheads) you don't quite reach breakeven. Could be what's holding back the share price. Interested to hear their comments on this tomorrow.

[clocktower] 21/3/2023 11:00

Sellers starting to appear that might be turning from bulls to bears and looking to make a few quid by buying back in lower down the food chain I guess.

.6-.63 When consolidated will we be looking at a lower figure as the market already is not loving the news it seems to me.

Good Luck though each to their own.

[quazie12] 21/3/2023 09:48

You talk complete utter guff with no basis. Clearly never been involved with the realities of running a business. Check back and at no stage have management over promised since Covid. Now if you want todebate a bear thesis on this company and make real points, then happy to do so, otherwise trott on.

[daz] 21/3/2023 08:36

A pre tax profit of £1m is forecast for 2024, not that far away. They just need to maintain 20 - 25% revenue growth, which looks eminently doable

[sos100] 21/3/2023 08:35

did you even bother to read results properly?

"For the avoidance of doubt, there is no present intention to raise any equity capital or issue any further shares in relation to our growth plans as Tissue Regenix is more than adequately funded to execute on its strategy."

"A combination of the team that we have in place; the products we currently have and the pipeline of new products we are developing; the commercial relationships we have and the distribution base that we have established all give the Board optimism about the future, both short and long term, for the Company. We believe that we are extremely well positioned to take advantage of the opportunities in front of us and to create a profitable, sustainable, cash generative company for shareholders."

----

it's slow burner here and will take time,if your not prepared to wait maybe 1 year then move out and try another share?

If there's genuine alarms or some concerns with these results then i want to hear as iv'e been caugut out lots of times it but not non issues...

[clocktower] 21/3/2023 08:26

So here is another negative for you SOS100 - A drop of over 2 million USD in the year.

"Cash position at 31 December 2022 of USD 5,949k (2021: USD 7,709k ) to support the current business growth plan"

How long will it now be before there is a REAL profit?

[sos100] 21/3/2023 07:31

your a trader so you would search for negatives....how is consolidation a major negative 😂

[clocktower] 21/3/2023 07:20

Now we know why there were big blocks being sold off - Consolidation - I do not like it one bit!

There will be a lot more liquidating now I expect.

[sos100] 21/3/2023 07:18

Jonathan Glenn, Chair of Tissue Regenix, commented: "During what has been a year of immense progress with some notable milestones achieved, we have continued to demonstrate and realise operational and commercial growth . This has been the result of our continued focus on our 4S strategy - Supply, Sales Revenue, Sustainability and Scale. We have experienced over 20% revenue growth across the Group, resulting in a positive adjusted EBITDA for the fourth quarter of 2022. Execution of this strategy will continue to provide us with the opportunity to build shareholder value as we broaden our opportunities in regenerative medicine, addressing many critical unmet clinical needs around the globe."

[emeraldzebra] 14/3/2023 12:02

Any ideas for a reason behind today’s slip up ?

[mickhay3] 10/3/2023 16:03

Looking good https://ibb.co/Y2qw3HX

[clocktower] 10/3/2023 10:09

Holding up well so far in a depressed market, so hopefully will bounce high when better times arrive.

[daz] 06/3/2023 13:14

Results now confirmed for Tue Mar 21st, so I think some buying ahead of results can be expected. It looks like the overhang, which was there on Friday has been cleared, as some buys are going through at the full ask

[clocktower] 06/3/2023 11:58

Hopefully heading up again now.

[daz] 03/3/2023 20:12

There looks to be an overhang as the offer quoted today was below the mid-price. So what look like sells today are probably buys, the price was good enough for me to add.

Results last year were on the 15th, so they will probably come out the week after next.
Forecasts for 2023 are for a 20% increase in revenues, having just done 25% for 2022 and with some new products to add incremental revenue, that looks quite achievable and there must be a good chance of them doing better.

[clocktower] 28/2/2023 12:35

Starting to look undervalued again imo.

[bamboo2] 09/2/2023 19:08

Tissue Regenix Group plc@TRX_plc 1h

👋Hello from Los Angeles and the #ACFAS2023!

We're here to showcase DERMAPURE, our next-generation decellularized dermal allograft.

Want to chat? You can find us at booth 738

[cyberbub] 09/2/2023 12:30

The 222m trade at 0.64 surely can't have been a sell? There were nowhere near enough buys above that price in the last couple of weeks, to fill the sell? It must be a 'worked' buy over a month or so IMO?

[tnt99] 08/2/2023 17:00

I concurr this must have been in the mix will be interesting who sold so much just as the company is coming good just hope it wasn't anything bloody director or I'll be after their head lol

[suresure] 08/2/2023 11:47

It's just over 3% of the company. If real it would have taken several weeks to work through. It might explain the muted response to the break even news. Must be a TR-1 incoming if it is real.

[tnt99] 08/2/2023 10:16

What is happening massive sell buys No movement in share price?